Highlights
NASDAQ: ACOR       Acorda Therapeutics
Last Price Today's Change   Day's Range   Trading Volume
7.434   -0.606 (7.54%)  7.36 - 8.66  560,580

Overview

 
Avg Volume (4 weeks):3,958,258
4 Weeks Range:0.676 - 8.66
4 Weeks Price Volatility (%):
84.64%
52 Weeks Range:0.42 - 8.66
52 Weeks Price Volatility (%):
85.12%
Average Price Target: 42.00
Price Target Upside/Downside: +34.566

Headlines



No recent Headlines for this stock.


Business Background

Acorda Therapeutics is a biotechnology company that identifies, develops, and commercializes novel therapies for neurological disorders. Acorda uses scientific, clinical, and commercial expertise in neurology as strategic points of access in additional nervous system markets, including stroke, Parkinson’s disease, and epilepsy. The company does not operate separate lines of business with respect to any of its products or product candidates. All of its net product revenue is derived from the United States.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

1946  4422  280  3253 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NAKD 0.491+0.055 
 F 11.59+0.73 
 ACST 0.855+0.099 
 BBIG 6.83+5.29 
 LK 1.38+1.38 
 CLSN 1.67+0.395 
 WPX 9.43+0.48 
 CTRM 0.343+0.018 
 SNDL 0.654-0.027 
 ADTX 4.38+1.77